Trials / Unknown
UnknownNCT05079438
Dendrobium Huoshanense Suppository in Rectal Cancer
A Multicenter Randomized Controlled Stage III Clinical Study of Dendrobium Huoshanense Suppository in Locally Advanced Rectal Cancer Patients Treated by Neoadjuvant Chemoradiotherapy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 168 (estimated)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluates the role of Dendrobium Huoshanense Suppository for radiation proctitis in locally advanced rectal cancer treated by capecitabine and irinotecan based neoadjuvant chemoradiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dendrobium Huoshanense Suppository | 1.7g rectal administration per day for 5 weeks |
Timeline
- Start date
- 2021-09-07
- Primary completion
- 2023-07-30
- Completion
- 2024-08-31
- First posted
- 2021-10-15
- Last updated
- 2021-10-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05079438. Inclusion in this directory is not an endorsement.